EU Grants

The BeYond-COVID project aims to make COVID-19 data accessible to scientists in laboratories but also to anyone who can use it, such as medical staff in hospitals or government officials.

Going beyond SARS-CoV-2 data, the project will provide a framework for making data from other infectious diseases open and accessible to everyone.

BBMRI-ERIC's CS IT team and its linked third parties contribute to this project.

The CY-Biobank project revolves around the upgrading of the existing Biobank of the University of Cyprus, to a Center of Excellence in Biobanking and Biomedical Research, adapting European standards of operation in collaboration with the Advanced Partners. This medical research infrastructure will then serve the foundation for developing the Cyprus human genome project and other genomics/genetics projects for diseases with Mendelian inheritance as well as complex disorders of multifactorial character that impact modern societies.

BBMRI-ERIC's PM, QM, and ELSI teams and their linked third parties contribute to this project.

The project DIAMONDS will address the challenge of bringing personalised medicine into routine use in EU healthcare systems for diagnosis and treatment of common infectious and inflammatory diseases, which account for a up to a third of all medical encounters in primary care and hospital.

BBMRI-ERIC's ELSI team and its linked third parties contribute to this project.

The European Health Data Space will address health-specific challenges to electronic health data access and sharing. The general objective is to ensure that natural persons in the EU have increased control in practise over their electronic health data. It also aims to ensure a legal framework consisting of trusted EU and Member State governance mechanisms and a secure processing environment.

BBMRI-ERIC's CS IT and Legal teams and their linked third parties contribute to this project.

EOSC Future will unlock the potential of European research via a vision of Open Science for Society by (1) bringing all major stakeholders in the EOSC ecosystem together under one project umbrella to break the disciplinary and community silos and consolidate key EOSC project outputs, (2) developing scientific use cases in collaboration with the thematic communities showcasing the benefits and societal value of EOSC for doing excellent and interdisciplinary research, (3) engaging the wider EOSC community and increasing the visibility of EOSC through communications campaigns, marketing strategies, and physical and online engagement events, and (4) including the EOSC community in developing the EOSC Portal (including the long tail of science, public and private sectors, and international partners) via co-creation open calls.

BBMRI-ERIC's CS IT team and its linked third parties contribute to this project.

EOSC4Cancer will make diverse types of cancer data accessible: genomics, imaging, medical, clinical, environmental and socio-economic. It will use and enhance federated and interoperable systems for securely identifying, sharing, processing and reusing FAIR data across borders and offer them via community-driven analysis environments.

BBMRI-ERIC's ELSI, QM, and IT teams and their linked third parties contribute to this project.

The European Platform for Neurodegenerative Diseases (EPND) will tackle the above issues by developing a self-sustaining European-based platform to facilitate discovery and access of relevant bio-samples and data.

BBMRI-ERIC's QM, Public Affairs, PM, and ELSI teams and their linked third parties contribute to this project.

EuCanImage is a new large-scale international project (10 million Euros) funded by the European Commission to build a secure and federated imaging platform for next-generation artificial intelligence in oncology. The EuCanImage platform will be populated with a new data resource totalling over 25,000 single subjects, which will allow to investigate unmet clinical needs like never before, such as for the detection of small liver lesions and metastases of colorectal cancer, or for estimating molecular subtypes of breast tumours and pathological complete response.

BBMRI-ERIC's ELSI and OEC teams and their linked third parties contribute to this project.

The aim of INTERVENE is to develop and test next generation tools for disease prevention, diagnosis, and personalised treatment utilizing the first US-European pool of genomic and health data and integrating longitudinal and disease-relevant -omics data into genetic risk scores. Resulting in unprecedented potential for prediction, diagnosis, and personalised treatments for complex and rare diseases. Some of the largest biobanks in Europe and two in the USA will be securely linked and harmonized in a GDPR-compliant repository with data from more than 1.7 million genomes.

BBMRI-ERIC's ELSI team and its linked third parties contribute to this project.

The ISIDORe consortium, made of the capacities of European ESFRI infrastructures and coordinated networks, proposes to assemble the largest and most diverse research and service providing instrument to study infectious diseases in Europe, from structural biology to clinical trials.

BBMRI-ERIC's QM, PM, CS IT, and OEC teams and their linked third parties contribute to this project.